Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

On identifying a positive dose-response surface for combination agents.

H M Hung1

  • 1Statistical Evaluation and Research Branch, Food and Drug Administration, Rockville, MD 20857.

Statistics in Medicine
|March 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drug profiling: a new scientific contribution to law enforcement operations in Viet Nam.

Bulletin on narcotics·2011
Same author

Group sequential test strategies for superiority and non-inferiority hypotheses in active controlled clinical trials.

Statistics in medicine·2001
Same author

Modification of sample size in group sequential clinical trials.

Biometrics·2001
Same author

Evaluation of a combination drug with multiple doses in unbalanced factorial design clinical trials.

Statistics in medicine·2000
Same author

Use of two-stage test statistic in the two-period crossover trials.

Biometrics·1997
Same author

Large sample tests for binary outcomes in fixed-dose combination drug studies.

Biometrics·1997
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
See all related articles

This study introduces a confidence surface to pinpoint optimal drug dosages for combination therapies. This method enhances the assessment of treatment effectiveness by analyzing dose-response relationships.

Area of Science:

  • Pharmacology
  • Biostatistics
  • Drug Development

Background:

  • Combination therapies require precise dosage determination for maximum efficacy.
  • Understanding the dose-response surface is crucial for optimizing treatment strategies.

Purpose of the Study:

  • To develop a confidence surface for tangential slopes of the dose-response surface.
  • To identify specific drug dosage ranges where therapeutic response increases.
  • To extend this approach for assessing the overall effectiveness of combination therapies.

Main Methods:

  • Construction of a confidence surface.
  • Analysis of tangential slopes of the dose-response surface.
  • Statistical modeling of drug dosage effects.

Related Experiment Videos

Main Results:

  • The confidence surface effectively identifies regions of increasing response with increasing drug dosage.
  • The approach provides a quantitative measure for assessing combination therapy effectiveness.
  • Demonstrated the utility of the confidence surface in dose-response analysis.

Conclusions:

  • The developed confidence surface is a valuable tool for optimizing combination therapy dosages.
  • This statistical approach aids in understanding and improving drug efficacy.
  • Further application in clinical settings can enhance treatment outcomes.